Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page
- Check16 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed trial information and inclusion criteria for a clinical study on talazoparib, while adding new identifiers and collaborators.SummaryDifference8%
- Check120 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check142 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check149 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference0.8%
- Check164 days agoChange DetectedSeveral key URLs related to genetics, clinical trials, and medical resources have been removed, indicating a significant reduction in available information on these topics.SummaryDifference2%
- Check171 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added including links to MedlinePlus, PubMed articles, and clinical trial documents, while the previous version 2.12.1 has been removed.SummaryDifference2%
Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.